Dr Patrick Brown presents data at ASH 2019 showing the improved survival of children and young adults with relapsed B-cell acute lymphoblastic leukaemia (B-ALL) when they were given blinatumomab compared with standard chemotherapy.
Watch our interview with Dr Brown here.
Read more about the study here.